Potential dopamine-1 receptor stimulation in hypertension management.
about
The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease.Activation of D4 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cellsAge-related hypertension and salt sensitivity are associated with unique cortico-medullary distribution of D1R, AT1R, and NADPH-oxidase in FBN rats.Inhibitors of 20-hydroxyeicosatetraenoic acid (20-HETE) formation attenuate the natriuretic effect of dopamine.Novel role of NF-κB-p65 in antioxidant homeostasis in human kidney-2 cells.Stimulation of Dopamine D3 Receptor Attenuates Renal Ischemia-Reperfusion Injury via Increased Linkage With Gα12.Enhanced Natriuresis and Diuresis in Wistar Rats Caused by the Costimulation of Renal Dopamine D3 and Angiotensin II Type 2 Receptors.Renal dopamine and angiotensin II receptor signaling in age-related hypertension.Direct inhibition of basolateral Kir4.1/5.1 and Kir4.1 channels in the cortical collecting duct by dopamineHuman kidney-2 cells harbor functional dopamine D1 receptors that require Giα for Gq/11α signaling.Dopamine D1 and D5 receptors differentially regulate oxidative stress through paraoxonase 2 in kidney cells.Primary Pediatric Hypertension: Current Understanding and Emerging Concepts.D5 dopamine receptor decreases NADPH oxidase, reactive oxygen species and blood pressure via heme oxygenase-1.Pharmacological analysis of dopamine modulation in the Drosophila melanogaster larval heart.Regulation of blood pressure, oxidative stress and AT1R by high salt diet in mutant human dopamine D5 receptor transgenic mice.Activation of angiotensin II type 1 receptors increases D4 dopamine receptor expression in rat renal proximal tubule cells.
P2860
Q30360038-FCD955AF-712F-4C1B-89F4-A63812D108E9Q34715754-1005C104-A527-4C8D-9BF2-074CC2CA6973Q35556214-289D7E4E-D464-4E1B-ACEB-F79120075C36Q36007749-E68E69E5-8C03-4C27-875C-FA5D634E30ADQ36042205-72F76587-0411-4BD6-8496-F169D6B7617EQ36201833-B4D5DA2B-5CEF-4A20-A6F6-DA666ECA690AQ36363450-BA81A6B2-3E02-4AED-A726-8C0E14098907Q36527864-4A7DFB2D-42B8-4B14-B5AC-6CD7714105EBQ37342011-C8F9D5E3-B9E7-4142-90F4-36AEF454DF30Q37476609-C63C86A6-F873-4ACC-B290-BB563A1C7ED7Q37603724-BAA1974B-FFCD-45FA-BCD1-5F3BF3B4CF25Q40105112-14F7AF43-A609-46CF-8B54-85A219DF6118Q40828206-7E13A881-7CE2-41CA-AA9A-A156115A4C2AQ42881321-97AF3A99-A198-4D0C-8EE9-F23DAA050E40Q46767521-A5B7FEC6-B455-4D61-A3D1-E3B5EAA09C9EQ51125962-C5C4C425-5EF1-42BB-9610-899B4E262AE0
P2860
Potential dopamine-1 receptor stimulation in hypertension management.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Potential dopamine-1 receptor stimulation in hypertension management.
@en
Potential dopamine-1 receptor stimulation in hypertension management.
@nl
type
label
Potential dopamine-1 receptor stimulation in hypertension management.
@en
Potential dopamine-1 receptor stimulation in hypertension management.
@nl
prefLabel
Potential dopamine-1 receptor stimulation in hypertension management.
@en
Potential dopamine-1 receptor stimulation in hypertension management.
@nl
P2093
P2860
P1476
Potential dopamine-1 receptor stimulation in hypertension management.
@en
P2093
Mohammad Asghar
Mustafa F Lokhandwala
Seyed K Tayebati
Tahir Hussain
P2860
P2888
P304
P356
10.1007/S11906-011-0211-1
P577
2011-08-01T00:00:00Z